20
IRUS TotalDownloads
Altmetric
Lung development genes and adult lung function
File | Description | Size | Format | |
---|---|---|---|---|
rccm.201912-2338oc.pdf | Published version | 592.99 kB | Adobe PDF | View/Open |
Title: | Lung development genes and adult lung function |
Authors: | Portas, L Pereira, M Shaheen, SO Wyss, AB London, SJ Burney, PGJ Hind, M Dean, CH Minelli, C |
Item Type: | Journal Article |
Abstract: | RATIONALE: Poor lung health in adult life may occur partly through suboptimal growth and development, as suggested by epidemiological evidence pointing to early life risk factors. OBJECTIVES: To systematically investigate the effects of lung development genes on adult lung function. METHODS: Using UK Biobank data, we tested the association of 391 genes known to influence lung development with FVC and FEV1/FVC. We split the dataset into two random subsets of 207,616 and 138,411 individuals, using the larger to select the most promising signals and the smaller for replication. MEASUREMENTS AND MAIN RESULTS: We identified 55 genes, of which 36 (16 for FVC; 19 for FEV1/FVC; 1 for both) had not been identified in the largest, most recent genome-wide study of lung function. Most of these 36 signals were intronic variants; expression data from blood and lung tissue showed that the majority affect the expression of the genes they lie within. Further testing of 34 of these 36 signals in the CHARGE and SpiroMeta consortia showed that 16 replicated after Bonferroni correction and another 12 at nominal significance level. 53 of the 55 genes fell into four biological categories whose function is to regulate organ size and cell integrity (growth factors; transcriptional regulators; cell-cell adhesion; extra-cellular matrix), suggesting that these specific processes are important for adult lung health. CONCLUSIONS: Our study demonstrates the importance of lung development genes in regulating adult lung function and influencing both restrictive and obstructive patterns. Further investigation of these developmental pathways could lead to druggable targets. |
Issue Date: | 15-Sep-2020 |
Date of Acceptance: | 11-May-2020 |
URI: | http://hdl.handle.net/10044/1/79870 |
DOI: | 10.1164/rccm.201912-2338OC |
ISSN: | 1073-449X |
Publisher: | American Thoracic Society |
Start Page: | 853 |
End Page: | 865 |
Journal / Book Title: | American Journal of Respiratory and Critical Care Medicine |
Volume: | 202 |
Issue: | 6 |
Copyright Statement: | © 2020 by the American Thoracic Society. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org). |
Sponsor/Funder: | Royal Brompton & Harefield NHS Foundation Trust Royal Brompton & Harefield NHS Foundation Trust |
Funder's Grant Number: | B1064 B1064 |
Keywords: | COPD FEV1/FVC FVC UK Biobank genetic association study Genetic association study; UK Biobank; FVC; FEV1/FVC; COPD Respiratory System 11 Medical and Health Sciences |
Publication Status: | Published |
Conference Place: | United States |
Online Publication Date: | 2020-05-11 |
Appears in Collections: | Department of Infectious Diseases National Heart and Lung Institute Faculty of Medicine |
This item is licensed under a Creative Commons License